Risperidone-induced acromegaly: a case report.

Abstract

Today, considering their adverse side effects, the first-generation antipsychotics have been replaced by the new-generation antipsychotics (also known as second-generation antipsychotic agents). The superiority of new-generation antipsychotics compared with first-generation antipsychotic agents in terms of side effects, especially movement disorders, are acknowledged by clinicians. But in recent years during the use of second-generation antipsychotic agents, endocrine side effects have been noteworthy. In our study with a diagnosis of paranoid schizophrenia treated with risperidone for 14 years and operated with the diagnosis of pituitary macroadenoma, a 32-year-old female patient is presented in the light of the literature examining the framework of the history of disease.

• Authors: Ayşe Koroglu, Cicek Hocaoglu
• Journal: Therapeutic advances in psychopharmacology (Ther Adv Psychopharmacol) Vol. 2 Issue 2 Pg. 85-9 (Apr 2012) ISSN: 2045-1253 [Print] England
• PMID: 23983960 (Publication Type: Journal Article)